書籍詳細

1. 炎症リウマチ

P.12 掲載の参考文献

• 1) Walton, J. N., Adams R. D.:Polymyositis, Livingstone, Edinburgh, 31-32, 1958.

• 2) 西海正彦:多発性筋炎と皮膚筋炎, 膠原病, アレルギーの臨床, 本間, 入交編, 朝倉書店, 71-92, 1975.

• 3) Nishikai, M., Reichlin, M.:Radioimmunoassay of serum myoglobin in polymyositis and other conditions. Arthritis Rheum, 20:1514-1518, 1977.
  pubmed

• 4) Pearson, C. M.:Patterns of polymyositis and their responses to treatment. Ann Intern Med, 59:827-838, 1963.
  pubmed

• 5) Pearson CM.:Polymyositis and dermatomyositis, Arthritis and Allied Conditions, McCarty DJ, ed., 9th ed., Lea and Febiger, Philadelplia, 742-761, 1979.

• 6) World Federation of Neurology, Research Group on Neuromuscular Diseases:Classification of the neuromuscular disorders. J Neurol Sci, 6:165-177, 1968.

• 7) Schraeder, P. L, Peters H. A, Dahl D. S.:Polymyositis and penicillamine. Arch Neurol, 27:456-457, 1972.
  pubmed

• 8) Nishikai, M., Funatsu, Y., Homma, M.:Monoclonal gammopathy, penicillamine-induced polymyositis and systemic sclerosis. Arch Dermatol, 110:253-255, 1974.
  pubmed

• 9) Bettendorf, U., Neuhans, R.:Penicillamine-induzierte Polymyositis. Dtsch Med Wshr, 99:2522-2526, 1974.

• 10) Pitkeathly, D. A., Coomes EN.:Polymyositis in rheumatoid arthritis. Ann Rheum Dis, 25:127-132, 1966.
  pubmed

• 11) Decker, J. L.:American Rheumatism Association nomenclature and classification of arthritis and rheumatism (1983) . Arthritis Rheum, 26:1029-1032, 1983.
  pubmed

• 12) 西海正彦, 本間光夫:多発性筋炎 (皮膚筋炎) の臨床, 現代の臨床, 6:324-331, 1972.

• 13) Nishikai, M.:Polymyositis and myopathies in collagen diseases. Ryumachi, 14:12-21, 1974.
  pubmed

• 14) Takats, G., Fowler, E. F.:Raynaud's phenomenon. JAMA, 179:1-8, 1962.
  pubmed

• 15) Nishikai, M., Reichlin, M.:Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Arthritis Rheum, 23:881-888, 1980.
  pubmed

• 16) Yoshida, S., et al.:The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. Arthritis Rheum, 26:604-611, 1983.

• 17) Medsger, T. A., Jr., et al:The epidemiology of polymyositis. Am J Med, 48:715, 1970.
  pubmed

• 18) Nishikai, M., et al.:Circulating autoantibody against human myoglobin in polymyositis. JAMA, 237:1842, 1977.
  pubmed

• 19) Arnett, F. C., et al.:The Jo-1 antibody system in myositis:Relationships to clinical features and HLA. J. Rheumatol 8:925, 1981.
  pubmed

• 20) Rosa, M. D., et al.:A mammalian tRNA-His containing antigen is recognized by the polymyositis specific antibody anti-Jo-1. Nucl. Acid Res, 11:853, 1983.

• 21) Mimori, T., et al.:Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in the sera from patients with polymyositis-scleroderma overlap. J Clin Invest, 68:611, 1981.
  pubmed

• 22) Nishikai, M., et al.:Purification and characterization of a nuclear none-histone basic protein (Mi-1) which reacts with anti-immunoglobulin sera and the sera of patients with dermatomyositis. Mol Immunol, 17:1129, 1980.

• 23) Hardin, J. A., et al.: The epidemiology of polymyositis. Am J Med, 48:715, 1970.

• 24) Epstein, P., et al:Identification of three different anti-4S RNA sera associated with autoimmane disease. Biochem Biophys Res Commun, 109:548, 1982.
  pubmed

• 25) Nakao, Y., et al.:A novel antibody which precipitates 7.5S RNA is located from a patient with autoimmune disease. Biochem Biophys Res Comm, 109:1332, 1982.

P.37 掲載の参考文献

• 1) Sharp, G. C., Irvin, W. S. , Tan, E. M., et al.:Mixed connective tissue disease:an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) . Am. J. Med., 52:148-159, 1972.

• 2) Sharp, G. C., Irvin, W. S., May, C. M., et al.:Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systemic lupus erythematosus and other rheumatic diseases. New Eng. J. Med., 295:1149-1154, 1976.
  pubmed

• 3) Sharp, G. C.:Mixed connective tissue disease. Bull Rheum. Dis., 25:828-831, 1974-75.

• 4) Sharp, G. C.:Mixed connective tissue disease-Overlap syndrome. Clinics Rheum Dis., 1:561-572, 1975.

• 5) Sharp, G. C.:Mixed connective tissue disease. Current concepts. Arthritis Rheum., 20:S181-186, 1977.

• 6) Sharp, G. C.:Mixed connective tissue disease and overlap syndromes. in"Textbook of Rheumatology", ed. W. N. Kelley, W. B. Saunders, 1151-1161. 1981.

• 7) 宮脇昌二, 古田嘉男, 小豆沢秀夫:Overlap症候群とMCTD. Medicina, 18:982-984, 1981.

• 8) 宮脇昌二, 小豆沢秀夫, 古田嘉男:当科におけるMixed Connective Tissue Diseaseの臨床像, 治療ならびに経過. 厚生省膠原病治療調査研究班昭和56年度研究業績, 105-111, 1981.

• 9) 宮脇昌二, 小野寺英朗, 坂本賢司:抗RNP, Sm抗体の疾患分布と39例のMCTDの臨床像. 厚生省MCTD調査研究班昭和57年度研究報告書, PP 128-134, 1983.

• 10) 宮脇昌二:抗ENA抗体. 検査と技術, 10:868-873, 1982.

• 11) 宮脇昌二, 小豆沢秀夫, 古田嘉男:体液性免疫反応の臨床的意義と評価. リウマチ, 22:435-437, 1982.

• 12) 宮脇昌二, 古田嘉男, 小豆沢秀夫:初期または不全型膠原病症例に関する検討. 厚生省膠原病治療調査研究班昭和55年度研究業績, PP 61-65, 1980.

• 13) Notman, D. D., Kurata, N. & Tan, E. M.:Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann. Int. Med., 83:464-469, 1975.
  pubmed

• 14) Gaudreau, A., Amor, B., Kahn, M. F., et al.:Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA) . Ann. Rheum. Dis., 37:321-327, 1978.
  pubmed

• 15) Lemmer, J. P., Curry, N. H., Mallory, J. H., et al.:Clinical characteristics and course in patients with high titer anti-RNP antibodies. J. Rheum., 9:536-542, 1982.
  pubmed

• 16) Singsen, B. H., Swanson, V. L, Bernstein, B. H., et al.:A histological evaluation of mixed connective tissue disease in childhood, Amer. J. Med., 68:710-717, 1980.
  pubmed

• 17) Alarcon-Segovia, D.:Symptomatic Sjgoren's syndrome in mixed connective tissue disease J. Rheum., 3:191-195, 1976.

• 18) Singsen, B. H., Kornreich, H. K., Koster-king, K., et al.:Mixed connective tissue disease in children. Arthritis Rheum., 20:355-360, 1977.
  pubmed

• 19) Grant, K. D., Adams, L E. & Hess, E. V.:Mixed connective tissue disease-A subset with sequential clinical and laboratory features. J. Rheum., 8:587-598, 1981.
  pubmed

• 20) Tan, E. M., Cohen, A. S., Fries, J. F., et al.:The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheurr., 25:1271-1277, 1982.
  pubmed

• 21) Masi, A. T., Rodnan, G. P., Medsger, T, A, Jr., et al.:Preliminary criteria for the classification of systemic sclerosis (Scleroderma) . Arthritis Rheum., 23:581-590, 1980.

• 22) Bohan, A, Peter, J. B., Bowman, R. L, et al.:A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Me-dicine, 56:255-286, 1977.

• 23) 東條毅, 富井正邦, 岡本 尚:Mixed connective tissue disease.-最近の話題から. 最新医学, 84:2126-2132, 1979.

• 24) 東條毅:膠原病のoverlapとMCTD. 感染・炎症・免疫, 13:15-22, 1983.

• 25) 本間光夫:膠原病の臨床. 日内会誌, 70:1-15, 1981.

• 26) 本間光夫, 高野 慎, 秋月正史他:Mixed connective tissue disease. 日本臨床41:1194-1200, 1983.

• 27) Nimelstein, S. H., Brody, S., McShane, D., et al.:Mixed connective tissue disease:A subsequent evaluation of the original 25 patients. Medicine, 59:239-248, 1980.
  pubmed

• 28) Jones, M. G., Osterholm, R. K., Wilson, R. B., et al.:Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease. Am. J. Med., 65:855-863, 1978.

• 29) 細田泰弘, 富永教洋, 東條 毅他:肺高血圧症を伴い臨床的に "Mixed Connective Tissue Disease (MCTD) "と診断された一剖検例. リウマチ, 21:325-333, 1981.

P.54 掲載の参考文献

• 1) Alcalay, M., Alcalay, D., Vincent, F., Ziegler J. E. and Bontoux, D.:HLA-D antigens and rheumatoid arthritris. Revue de Rhumatisme, 15th International Congress of Rheumatology:3, 1981.

• 2) Bardin, Th., Dryll, A., Debeyre, N., Ryckewaert, A., Legrand, L, Marcelli, A. and Dausset, J.:HLA system and gold side effects in rheumatoid arthritis (RA) . Revue du Rhumatisme, 15th International Congress of Rheumatology:171, 1981.

• 3) Brewer, E. J.:The major histocompatibility complex and its association with rheumatoid disease. in Juvenile Rheumatoid Arthritis (ed. by Brewer, E. J, Gianni, E. H. and Person, D. A.) . Philadelphia, W. B. Saunders Co., 1982.

• 4) Brewerton, D. A., Hart, F. D., Nicholls, A., Caffney, M., James, D. G. O., Sturrock, R. D.:Ankylosing spondylitis and HL-A27, Lancet, i:904, 1973.

• 5) Dobloug, J. H., Forre, O, Kass, E., Thorsby, E.:HLA antigens and rheumatoid arthritis. Association between HLA-DRW4 positivity and IgM rheumatoid factor production. Arthritis Rheum., 23:309-313, 1980.
  pubmed

• 6) Husby, G., Gran, J. T. and Thorsy, E.:Increased frequency, but no prognostic significans of HLA-DR4 in rheumatoid arthritis in Norway. Revue du Rhumatisme, 15th International Congress of Rheumatology:6, 1981.

• 7) 片桐一:HLA抗原の構造と機能について. 第4回HLA研究会学術講演集, 1981.

• 8) Nichol, F. E. and woodrow, T. J.:HLA-DR antigens in Indian patients with rheumatoid arthritis. Lancet 1:220-221, 1981.

• 9) Queiros, M. V., Caetano, J. M., Sancho, M. H. and Mateus, A. M.:HLA A, B, C, and DR antigens in the rheumatoid arthritis. Revue du Rhumatisme, 15th International Congress of Rheumatology:7, 1981.

• 10) Sakurami, T., Iwaki, Y., Park, M. S., Terasaki, P. Z. and Saji, H.:HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigens 19:129-133, 1982.

• 11) Scherak, O., Smolen, J. S. and Mayn, W. R.:Rheumatoid arthritis and Blymphocyte alloantigen HLA-DRW4. J. Rheumatology 7:9-12, 1980.

• 12) Sontheimer, R. D., Stasny, P., and Gilliam, J. N.:Human histocompaibility antigen associations in subacute cutaneous lupus erythematosus, J. Clin. Invest., 67:312-317, 1981.

• 13) Stasny, P.:Association of the B cell alloantigen DRW4 with rheumatoid arthritis. N. Engl. J. Med., 298:869-871, 1978.

• 14) 辻本正記, 七川歡次, 白倉良太:強直性脊椎炎とHL-A27について. 整形外科26:104-108, 1975.

P.74 掲載の参考文献

• 1) Arnette, F. C., et al.:Juvenile-onset chronic arthritis, Clinical and roentgen ographic features of a unique HLA-B27 subset:Am J Med, 69:369, 1980.

• 2) Balogh, Z., et al.:HLA-DR antigens in juvenile chronic arthritis:J Rheum, 9:448, 1982.
  pubmed

• 3) Brewerton, D. A., et al.:Ankylosing spondylitis and HL-A27:Lancet, 1:904, 1973.

• 4) Clemens, L. E., et al.:HLA studies in IgM rheumatoid-factor-positive arthritis childhood:Ann Rheum Dis, 42:431, 1983.
  pubmed

• 5) Dodd, M. J. and Carson, D. W.:Histocompatibility antigens and rheumatic diseases S Afr Med J, 61:425, 1982.

• 6) Edmonds, J. et al.:Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W27:Ann Rheum Dis, 33:289, 1974.

• 7) Fink, C. W. and Stastny, P.:Results of serologic HLA-DR typing in juvenile arthritis and adult RA:Arthritis Rheum, 23:676, 1980.

• 8) Forre, O., et al.:HLA antigens in juvenile arthritis:Arthritis Rheum, 26:35, 1983.
  pubmed

• 9) Fujikawa, S.:Extra-articuler manifestations of juvenile rheumatoid arthritis:Ryumachi, 21 (suppl):99, 1981.

• 10) Gershwin, M. E., et al.:Frequency of HLA-Dw3 in juvenile rheumatoid arthritis:Tissue Antigens, 10:330, 1977.
  pubmed

• 11) Gibson, D. J., et al.:Re-examination of histocompatibility antigens found in patients with juvenile rheumatoid arthritis:N Engl J Med, 293:636, 1975.
  pubmed

• 12) Glass, D. et al.:Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis and antinuclear antibody:J Clin Invest, 66:426, 1980.
  pubmed

• 13) Glass, D. and Litvin, D., A.:Heterogeneity of HLA associations in systemic onset juvenile rheumatoid arthritis:Arthritis Rheum, 23:796, 1980.
  pubmed

• 14) Havelka, S. et al.:Association of some features of juvenile rheumatoid arthritis with antigen HLA-B27:Rheumatologie (Paris), 12:109, 1982.

• 15) Miller, M. L.:The major histocompatibility complex antigens in rheumatoid arthritis and juvenile arthritis:Bull Rheum Dis, 31:21, 1981.
  pubmed

• 16) Morling, N. et al.:HLA-A, B, C, D, DR antigens and primed lymphocyte typing (PLT) defined DP-antigens in juvenile chronic arthritis:Tissue Antigens, 17:433, 1981.

• 17) Oen, K. et al.:An association between HLA-A2 and juvenile rheumatoid arthritis in girls:J Rheum, 9:916, 1982.
  pubmed

• 18) Rachelefesky, G. S. et al.:Increased prevalence of W27 in juvenile rheumatoid arthritis:N Engl J Med, 290:892, 1974.

• 19) Rossen, R. D., et al.:Familial rheumatoid arthritis. Linkage of HLA to disease susceptibility locus in four families where proband pesented with juvenile rheumatoid arthritis:J Clin Invest, 65:629, 1980.

• 20) Schaller, J. G., et al.:Histocompatibility antigens in childhood-onset arthritis:J Pediatr, 88:926, 1976.
  pubmed

• 21) Schaller, J. G.:The diversity of JRA. A 1976 lookk at the subgroups of chronic childhood arthritis:Arthritis Rheum, 20 (suppl 6):52, 1977.

• 22) Schlosstein, L. et al:High association of an HL-A antigen, W27, with ankylosing spondylitis:N Engl J Med, 288:704, 1973.

• 23) Stastny, P. and Fink, C., W.:Different HLA-D associations in adult and juvenile rheumatoid arthritis:J Clin Invest, 63:124, 1979.
  pubmed

• 24) Stastny, P. et al.:Rheumatoid Arthritis. Histocompatibility testing 1980. edited P. I. Terasaki, Los Angeles, UCLA Tissue Typing Laboratory, 681, 1980,

• 25) Sturrock, R. D., et al.:Association of HL-A27 and AJ in juvenile rheumatoid arthritis and ankylosing spondylitis:J Rheumatol 1:269, 1974.

• 26) Suciu-Foca, N. et al.:Increased frequency of DRw5 in pauciarticular JRA. Histocompatibility Testing 1980, edited P. I Terasaki, Los Angeles, UCLA Tissue Typing Laboratory, 953, 1980.

• 27) 寺脇保1第24,26回日本リウマチ学会発表.

• 28) Veys, E. M., et al.:HLA and juvenile chronic arthritis:Tissue Antigens, 8:61, 1976.
  pubmed

P.86 掲載の参考文献

• 1) Brewerton, D. A., et al.:Ankylosing spondylitis and HL-A 27. Lancet, 1:904-906, 1973.
  pubmed

• 2) Schlosstein, L et al.:High association of an HL-A antigen W 27 with ankylosing spondylitis. N. Engl J Med., 288:704-705, 1973.

• 3) Geczy, A. F., et al.:A survey of isolates of Klebsiella pneumonial which cross-react with HLA-B27-associated cell-surface structure on the lymphocytes of patients with ankylosing spondylitis. J. Rheumatol, 9:97-100, 1980.

• 4) 辻本正記ら:強直性脊椎炎の頻度と診断基準について. 臨床整形外科, 5:514-519, 1970.

• 5) Tsujimoto, M.:Epidemiological research on the prevalence of ankylosing spondylitis. Med J Osaka Univ., 28:363-381, 1978.
  pubmed

• 6) Gofton, J. P., et al.:Ankylosing spondylitis in a Canadian Indian population. Ann. Rheum. Dis., 25:525-531, 1966.

• 7) 辻本正記ら:強直性脊椎炎の有病率と鑑別診断. リウマチ, 17:124-126, 1977.

• 8) 辻本正記:強直性脊椎炎「図説臨床整形外科講座」メジカルビュー社, 1981.

• 9) Hawkins, B. R., et al.:Use of the B27 test in the diagnosis of ankylosing spondylitis:A statistical evaluation. Arth Rheum., 24:743-746, 1981.

• 10) Khan, M. A., et al.:Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Int. Med., 96:70-76, 1982.
  pubmed

• 11) 辻本正記:強直性脊椎炎の症例「関節リウマチとその周辺」, 金原出版, 1979.

• 12) 辻本正記ら:強直性脊椎炎とHLA-B27. 整形外科, 26:104-108, 1975.

• 13) Hill, HFH et al.:Clinical diagnosis of ankylosing spondylitis in women and relation to presence of HLA-B27. Ann. Rheum. Dis., 35:267-270, 1976.

• 14) Eastmond, C. J. et al.:Frequency of fecal Klebsiella aerogenes in patients with ankylosing spondylitis and control with respect to individual features of the disease. Ann. Rheum. Dis., 39:118-123, 1980.

2. 骨関節疾患

P.105 掲載の参考文献

• 1) Alves, L. E., and Rose, E. P.:Complication of steroid therapy for rheumatoid arthritis. Ann. Intern. Med. 94:713, 1981.
  pubmed

• 2) Bird, H. A., Wright, V., Hennes, U. and Theiss, E.:Comparison of serum 1, 25-dihydroxycholecalciferol concentrations in rheumatoid arthritis and osteoarthrosis. Ann. Rheum. Dis. 41:257-258, 1981.

• 3) Christiansen, C. and Rodbro, P.:Skeletal status in patients with rheumatoid arthritis. Acta med. scand. 198:453-454, 1975.
  pubmed

• 4) Cohn, S. H., and Ellis, K. J.:Predicting radial bone mineral content in normal subjects. Internat. J. Nucl. Med. and Biol. 2:53-57, 1982.

• 5) Cushing, H.:The basophil adenomas of the pituitary body and their clinical manifestation (pituitary basophilism) . Bull. Johns Hopkins Hosp. 50:137-,1932.

• 6) Duncan, H., Frost, H. M., Villanueva, A. R. and Sigler, J. W.:The osteoporosis of rheumatoid arthritis. Arthritis Rheum. 8:943, 1965.
  pubmed

• 7) Gluck, O., Murphy, W. Hahn, T. and Hahn, B.:Risk factors for steroid-induced bone loss. Arthritis Rheum. 23:681, 1980.

• 8) Gluck, O., Murphy, W., Hahn, T, Hahn, B.:Bone loss in adults receiving alternate day glucocorticoid therapy. Arthritis Rheum. 24:892-898, 1981.
  pubmed

• 9) Hadden, W. A., Abernethy, P. J. and Haw, C.:Hip fracture in rheumatoid arthritis. Clin. Orthop. 170:252-259, 1982.
  pubmed

• 10) 林泰史, 五十嵐三都男, 益田峯男, 軽部俊二, 織田弘美:慢性関節リウマチ患者の骨萎縮について-閉経期後女性例についての分析-. リウマチ21:385-391, 1981.

• 11) Howland, W. J., Pugh, D. G. and Sprague, R. G.:Roentgenologic changes of the skeletal system in Cushing's syndrome. Radiology 71:69-78, 1958.
  pubmed

• 12) Iannaccone, A., Gabrilove, J. L, Brahms, S. A. and Soffer, L. J.:Osteoporosis in Cushing's syndrome. Ann. Intern. Med. 52:570-586, 1960.

• 13) Kennedy, A. C., Smith, D. A., Grey, G., Jasani, M. K. and Buchanan, W. W.:Osteoporosis in patients with rheumatoid arthritis. Ann. Rheum. Dis. 34:542-543, 1975.

• 14) Kennedy. A. C., Boddy, K., Milliams, E. D., Elliott, A. T., Harvey, I., Holloway, I. and Haywood, J. K.:Whole body elemental composition during drug treatment of rheumatoid arthritis:a preliminary study. Ann. Rheum. Dis. 38:137-140, 1979.

• 15) Maddison, P. J. and Bacon, P. A.:Vitamin D deficiency, spontaneous fractures, and osteopenia in rheumatoid arthritis. Br. Med. J. 4:433-435, 1974.
  pubmed

• 16) 松井清明, 七川歡次:ラット脛骨X線像の皮質計測による経時推移観察法-加齢に伴う問題点について. 日骨代謝誌:13-21, 1984.

• 17) Matsui, K. and Shichikawa, K.:Usefulness of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) in the treatment of osteoporosis induced by oophorectomy in adult rats. JJBM 2:99-103, 1984.

• 18) 宮本繁仁, 井上哲郎, 串田一博, 福地正行, 傳田正志, 鈴木昌則:慢性関節リウマチにおける血中ビタミンD値と各種因子の検討. 中部整災誌 26:1440-1442, 1983.

• 19) O'driscoll, S. and O'driscoll, M.:Osteomalasia in rheumatoid arthritis. Ann. Rheum. Dis. 39:1-6, 1980.

• 20) Reid, D. M., Kennedy, N. S., Smith, M. A., Tothill, P. and Nuki, G.:Total body calcium in rheumatoid arthritis:effects of disease activity and corticosteroid treatment. Br. Med. J. 285:330-332, 1982.

• 21) Saville, P. D. and Kharmosh, O.:Osteoporosis of rheumatoid arthritis:Influence of age. sex and corticosteroids. Arthritis Rheum. 10:423-430, 1967.
  pubmed

• 22) Schorn, D.:Osteoporosis in the rheumatoid hand-the effects of treatment with d-penicillamine and oral gold salts. S. Afr. Med. J. 63:121-123, 1983.

• 23) Sissons, H. A.:The osteoporosis of Cushing's syndrome. J. Bone and Joint Surg. 38-B:418-433, 1956.

P.120 掲載の参考文献

• 1) Gluck, U. S., Murphy, W. A., Hahn, T.J., and Hahn, B.:Bone loss in adults receiving alternate day glucocerticoid therapy. -a compassion with daily therapy-Arthritis Rheum. 24:892-898, 1981.

• 2) Jowsey, J.:Bone density measurements. W. B. Saunders. 96-114, 1977.

• 3) Kennedy, A. C., and Lindsay, R.:Bone involvement in rheumatoid arthritis. Clinic in rheumatic disease 3:403-420, 1977.

• 4) 宮本繁仁, 井上哲郎, 串田一博, 萎沢利行, 福地正行, 傳田正史, 山下源太郎:慢性関節リウマチにおける骨粗鬆症の検討 整形外科. 34:1047-1052, 1983.

• 5) 大田幸一郎, 岡本幸春, 上江州朝洋, 富田健夫, 藤田哲男:慢性関節リウマチにおけるカルシウム代謝. 日内会誌, 66:6-11, 昭和52年.

3. 生物反応

P.130 掲載の参考文献

• 1) Linker-Israeli, M., Bakke, A. C., Kitridou, R. C. et al.:Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE) . J. Immunol. 130:2651, 1983.
  pubmed

• 2) Sakane, T., Steinberg, A. D., and Green, I.:Failure of autologous mixed lymphocyte reaction between T and non-T cells in patients with systemic lupus erythematosus. Proc. Natl. Acad, Sci. USA, 75:3464, 1978.
  pubmed

• 3) Fye, K. H., Moutosopoulos, H. and Talal, N.:"B and T lymphocytes in autoimmunity"in B and T cells in immune recognition, ed. by F. Loor, G. E. Rcelants (John willey and Sons, London, 1977) pp. 355.

• 4) Duke, O., Panayi, G. S., Janossy, G.:Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann. Rheum. Dis., 42:357, 1983.
  pubmed

• 5) Muraguchi, A., Kishimoto, T., Kuritani, T.et al.:In vitro immune response of human peripheral lymphocytes. VII effect of Anti-μ and Anti-δ antibodies on B colony formation and detection of abnormal B cells in patients with juvenile rheumatoid arthritis. J. Immunol, 125:2638, 1980.

• 6) Krakauer, R. S., Waldmann, T. A., Strober, W.:Loss of suppressor T cells in adult NZB/NZW mice, J. Exp. Med. 144:162, 1976.

• 7) Izui, S., McConahey, P.J., Dixon, F. J.:Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J. Immunol, 121:2213, 1978.
  pubmed

• 8) Yoshizaki, K., Nakagawa, T., Fukunaga, K. et al.:Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells. J. Immunol. 130:1241, 1983.
  pubmed

• 9) Okada, M., Sakaguchi, N., Yoshimura, N. et al.:B cell growth factors (BCGF) and B cell differentiation factor (BCDF) from human T hybridomas:Two distinkt kinds of BCGFs and their synergism in B cell proliferation. J. Exp. Med., 157:583, 1983.

• 10) Saiki, O., Shimizu, M., Saeki, Y. et al:Dissociative production of B cell stimulating factors (BCDF, BCGF) and interleukin 2 in a common variable immunodeficient patient. J. Immunol. in press.

• 11) Saiki, O., Ralph, P.:Clonal differences in response to T-cell replacing factor (TRF) for IgM secretion and TRF receptors in a human B-lymphoblast cell line. Eur. J.. Immunol. 13:31, 1983.

• 12) Prud'homme G. J., Park, C. L., Fieser, T. M. et al.:Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the 1pr/1pr genotype. J. Exp. Med. 157:730, 1983.

• 13) Kikutani, H., Taga, T., Akira, S., et al.:Effect of B cell differentiation factor (BCDF) on biosynthesis of immunoglokulin molecules in human B cell lines. 投稿中

P.143 掲載の参考文献

• 1) ロアット, I, M.:自己免疫. 免疫学要説 (原著第4版) 新井俊彦訳, 理工学社, 273-308, 1982.

• 2) 桜美武彦, 鈴木博史, 中山朝夫, 上野征夫, 知念良教:SLE.医学と薬学, 3:651-658, 1980.
  Medical*Online

• 3) 辻 公美:HLA研究, 最近の進歩と移植. 日本臨牀, 42:975-988, 1984.
  Medical*Online

• 4) Sakurami, T., Ueno, Y., Iwaki, Y., Park, M. S., Terasaki, P. I., Saji, H.:HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigens, 19:129-133, 1982.

• 5) Sakurami T., Ueno, Y., Okumura, H., Terasaki, P. I., Louie, S., Takemura, S.:HLA-DR specificities among Japanese with rheumatoid arthritis. Arthritis Rheum., 24:866, 1981.
  pubmed

• 6) Festenstein, H. and Demant, P.:The MHS and disease. in, 'HLA and H-2', , ed. J. Turk, London, Edward Arnold Ltd., 161-176, 1978.

• 7) Bernoco, D., and Terasaki, P. I.:HLA and disease. in 'Genetic control of autoimmune disease', , ed. N. R. Rose, P. E. Bigazzi, N. L. Warner, New York, Elsevier/North-Holland, 3-14, 1978.

• 8) 柳瀬敏幸:臨床遺伝学の動向. 日本臨牀, 42:754-766, 1984.
  Medical*Online

• 9) 山口雅也:遺伝子が表現されるときの変化. 遺伝性疾患, 朝倉書店, 35-47, 1974.

• 10) 板倉克明:HLAの意義. 内分泌疾患の免疫・遺伝学, 熊谷 朗, 伊藤眞次 編集, 共立出版, 10-23, 1981.

P.154 掲載の参考文献

• 1) 石川 斉:リウマチ関節炎の病理組織像とその発生機転, リウマチ病IV, 七川歡次編 永井書店. 1-25, 1977.

• 2) Hirohata, K., and Kobayashi, I.:Fine structures of syllovial tissues in rheumatoid arthritis. Kobe J. Med. Sci., 10:195-225, 1965.

• 3) Ishikawa, H., and Ziff, M.:Electron microscopic observations of immunoreactive cells in rheumatoid synovial membrane. Arthritis Rheum. 19:1-14, 1976.

• 4) Kobayashi, I., Ziff, M.:Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum. 16:471-486, 1973.
  pubmed

• 5) Andreis, M., Rosenthal, M., Stastny, P., Ziff, M.:Experimental arthritis produced by injection of mediators of delayed hypersensitivity. Arthritis Rheum. 17:537-551, 1974.

• 6) Seeger, RC., Oppenheim, JJ.:Synergistic interaction of macrophages and lymphocytes in antigen-induced transformation of lymphocytes. J. Exp. Med. 132:44-65, 1970.
  pubmed

• 7) Seeger, RC., Oppenheim, JJ.:Macrophage bound antigen. I. Induction of delayed hypersensitivity and priming for production of serum antibodies in quinea pigs. J. Immunol. 109:244-254, 1972.

• 8) David, JR.:Delayed hypersensitivity in vitro:its mediation by cell free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56:72-77, 1966.
  pubmed

• 9) Bennett, B., Bloom, BR.:Studies on the migration inhibitory factor associated with delayed hypersensitivity:cytodynamics and specificity. Transplantation 5:996-1000, 1967.

• 10) Ishikawa, H., Hirohata, K.:An immunoelectron microscopic study of the immunoglobulin synthesizing cells of the rheumatoid synovial membrane, Clin Orthop & related Research. 185:280-289, 1984.

• 11) Ferranini, M., Moretta, L., Abrile, R., et al.:Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells. Eur. J Immunol. 570-72, 1975,

• 12) Gmeling-Meyling, F., van der Ham, M., Bollieux RE.:Binding of IgM by human T lymphocytes. Scand J. Immunol. 5:487-495, 1976.

• 13) McConell, I., Hurd, CM.:Lymphocyte receptor II. Receptors for rabbit IgM on human T lymphocytes. Immunology 30:836-839, 1976.

• 14) Moretta, L, Ferrarini M, Durante ML. et al:Expression of a receptors for IgM by human T cells in vitro. Eur. J. Immunol. 5:565-560, 1975.

• 15) Moretta L, Webb, SR., Grossi, CE. et al.:Functional analysis of two human T cell subpopulations:help and suppression of B cell response by T cell bearing receptors for IgM (Tμ) or IgG (Tγ) . J. Exp. Med. 146:184-200, 1977.

• 16) Pape, GR., Moretta, L., Troye, M. et al.:Natural cytotoxicity of human Fc receptor positive T lymphocytes after surface modulation with immune complexes. Scand. J. Immunol. 9:291-296, 1979.
  pubmed

• 17) Bankhust, AD., Husby, G., Williams, RC Jr.:Predominance of T cells in the lymphocytic infiltrates of synovial tissue in rheumatoid arthritis Arthritis Rheum. 19:555-562, 1976.

• 18) Van-Boxel, JA., Paget, SA.:Predominantly T cell infiltrate in rheumatoid synovial membranes N Eng J. Med. 293:517-520, 1975.

• 19) Ishikawa, H., Matsubara, T., Hirohata, K.:Decreased number of Tr lymphocytes in rheumatoid synovial membrane. Kobe J. Med. Sci. 29:17-29, 1983.

• 20) 服部俊夫, 内山 卓, 高月 清:Tγ, Tμの測定法-Mixed rosette assay-免疫実験操作法8:2533-2540, 1979.

• 21) 石川斉, 鵜飼和浩, 大野修, 他:慢性関節リウマチ滑膜組織中のTγリンパ球とその意義について. 日整会誌57:285-291, 1983.

• 22) Abrahamsen, TG., Frφland SS, Natvig, JB et al.:Antigen and unspecific mitogen stimulation of lymphocytes eluted from rheumatoid inflammatory tissue. Scand. J. Immunol. 5:1057-1063, 1976.

• 23) Williams, RC., Jr.:Blood and tissue distribution of lymphocytes in rheumatoid arthritis. Rheumatol. 6:219-230, 1975.

• 24) Fox, RI., Fong, S., Sabharwal, N. et al.:Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J. Immunol. 128:351-354, 1981.

• 25) Janossy, G., Duke, O., Panayi, G. et al.:Rheumatoid arthritis:A disease of T lymphocyte/macrophage immunoregulation. Lancet 2:839, 1981.
  pubmed

• 26) Kurosaka, M., Ziff, M.:Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J. Exp. Mad. 158:1191-1210, 1983.

• 27) 石川 斉, 清水富男, 山崎京子, 他:RAにおける末梢血および滑液中のリンパ球subsets. 炎症 3:419-120, 1983.

P.171 掲載の参考文献

• 1) Zvaifler, N. J.:Etiology and pathogenesis of rheumatoid arthritis. Arthritis and Allie Conditions, 9th ed, Philadelphia, Lea & Febiger, 417-428, 1979.

• 2) Cooke, T., D. Hurd, E., R. Ziff, M. and Jasin, H. E.:The pathogenesis of chronic inflammation in experimental antigen-induced arthritis II. preferential localization of antigen-antibody complexes to collagenous tissues. J. Exp. Med 135:323-338, 1972.
  pubmed

• 3) Hollister, J., R. and Mannik, M.:Antigen retension in joint tissues in antigen-induced synovitis. Clin. Exp. Immunol 16:615-627, 1974.

• 4) Jasin, H. E.:Mechanism of trapping to immune complexes in joint collagenous tissues. Clin. Exp. Immunol 22:473-485, 1975.
  pubmed

• 5) Jasin, H. E. and Cooke, T. D.:The inflammatory role of lmmune complexes trapped in joint collagenous tissues. Clin. Exp. Immunol 33:416-424, 1978.

• 6) Cooke, T. D. Hurd, E. R. Jasin, H. E. Bienenstock, J. and ziff, M.:Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis. Rheum 18:541-551, 1975.S
  pubmed

• 7) Ishikawa, H. Smiley, J, D. and Ziff, M.:Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage. Arthritis. Rheum 18:563-576, 1975.
  pubmed

• 8) Weissmann, G.:Lysosomes and rheumatoid joint inflammation. Arthritis. Rheum 20:s194-204, 1977.

• 9) Henson, P. M.:Interaction of cells with immune complexes:Adherence, release of constituents, and tissue iniury. J. Exp. Med 134:114s-135s. 1971.

• 10) Ugai, K. Ziff, M. and Jasin, H. E.:Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissues. Arthritis. Rheum 22:353-364, 1979.
  pubmed

• 11) Ugai, K. Ishikawa, H. Hirohata, K. and Shirane, H.:Interaction of polymorphonuclear leukocytes with immune complexes trapped in rheumatoid articular cartilage. Arthritis. Rheum 26:1434-1441, 1983.
  pubmed

• 12) 鵜飼和浩, 原田俊彦, 石川 斉, 広畑和志:RA軟骨と多核白血球, マクロファージの相互作用 (第2報) 炎症3:427-428, 1983.

• 13) 原田俊彦, 正田悦朗, 鵜飼和浩, 石川 斉, 広畑和志:RA軟骨とマクロファージの相互作用 リウマチ23:509s.,1983.

• 14) Mohr, W. Westerhellweg, H.and Wessinghage, D.:Polymorphonuclear granulocytes in rheumatic tissue destruction. III. An electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis. Ann. Rheum. Dis 40:396-399, 1981.
  pubmed

• 15) Ohno, O. and Cooke, T. D.:Electron microscopic morphology of immunoglobulin aggregates and their interactions in rheumatoid articular collagenous tissues. Arthritis. Rheum 21:516-527, 1978.
  pubmed

• 16) Ward, P. A. and Zvaifler, N. J.:Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J. Clin. Invest 50:606-616, 1971.
  pubmed

• 17) Kemp, A.S.Roberts-Thomson, P. Neoh, S.H. and Brown, S.:Inhibition of neutrophil migration by sera from the patients with rheumatoid arthritis. Clin. Exp. Immunol 36:423-429, 1979.

• 18) Attia, W.M. Clark, H.W. Brown, T.M. Ali, M.K.H. and Bellanti, J. A.:Inhibition of polymorphonuclear leukocyte migration by sera of patients with rheumatoid arthritis. Ann. Allergy 47:21-24, 1981.

• 19) Matzner, Y. Partridge, R. E. H. and Babior, B. M.:A chemotactic inhibitor in synovial fluid. Immunology 49:131-138, 1983.
  pubmed

• 20) Forrester, J. V. and Wilkinson, P.C.:Inhibition of leukocyte locomotion by hyaluronic acid. J. Cell. Sci 48:315-331, 1981.
  pubmed

• 21) Hakansson, L Hallgren, R. and Venge, P:Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J. Clin. Invest 66:298-305, 1980.
  pubmed

4. 治療

P.189 掲載の参考文献

• 1) Rydell, N. W., Butler, J. and Balazs, E. A.:Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet. Scand., 11:139-155, 1970.
  pubmed

• 2) Rydell, N. W., and Balazs, E. A.:Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin. Orthop., 80:25-32, 1971.

• 3) Peyron, J. G., and Balazs, E. A.:Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Patho, Biol., 22:731-736, 1974.

• 4) Helfet, A. J.:Management of osteoarthritis of the knee joint. in``Disorders of the knee:, ed. A. J. Helfet, J. B. Lippincott Co., Philadelphia:175-194, 1974.

• 5) Weiss, C., Balazs, E. A., Onge, R.S. et al.:Clinical studies of intraarticular injection of Healon (sodium hyaluronate) in the treatment of osteoarthritis of human knees. Semin. Arthr. Rheum., 11:143-144, 1981.

• 6) 大島良雄, 東博彦, 並木脩, 他:変形性膝関節症に対する高分子量ヒアルロン酸ナトリウム (SPH) の関節腔内注射療法-多施設共同研究による臨床第II相試験-. 薬理と治療, 11:2253-2267, 1983.
  Medical*Online

• 7) 七川歡次, 五十嵐三都男, 菅原幸子, 他:変形性膝関節症に対する高分子量ビアルロン酸ナトリウム (SPH) の臨床評価-多施設臨床比較試験-. 臨床薬理, 14:545-558, 1983.

• 8) 七川歡次, 前田 晃, 小川暢也:変形性膝関節症に対するヒアルロン酸ナトリウム(SPH)の薬効検定. リウマチ, 23:280-290, 1983.

• 9) 七川歡次, 前田 晃, 小川暢也:変形性膝関節症に対するヒアルロン酸ナトリウム(SPH)の薬効検定-試験終了1ヵ月後の追跡調査-. 日本リウマチ協会薬効検定委. 員会報告 (未発表), 1983.

• 10) 五十嵐三都男, 小野沢敏弘, 村田正明, 他:変形性膝関節症に対する高分子量ヒアルロン酸ナトリウム(SPH)の多施設長期投与臨床試験. 薬理と治療, 11:4871-4888, 1983.
  Medical*Online

• 11) 新名正由, 稲岡正裕, 右近良治, 他:変形性膝関節症に対する高分子量ヒアルロン酸ナトリウムの注入療法-臨床効果と関節液の性状変化-. 膝, 9:108-113, 1983.

• 12) 並木 脩, 秋山文世, 長谷川 清, 他:変形性膝関節症関節液とヒアルロン酸代謝膝9:69-73, 1983.

• 13) Balazs, E. A., Briller, S. O. and Deneinger, L.:Na-hyaluronate molecular size variations in equine and human arthritic synovial fluids and the effect on phagocytic cells. Semin. Arthr. Rheum., 11:141-143, 1981.

• 14) 新名正由, 坂本崇:私信

• 15) 豊島弘道:実験的滑膜切除術後の関節軟骨変性とヒアルロン酸の変性抑制効 果に関する研究. 東京女子医大雑誌, 48:890-910, 1978.

• 16) 坂本崇, 山口敏二郎, 岩田久, 他:ヒアルロン酸と関節軟骨-軟骨表層に対するaffinityとプロテオグリカン遊出抑制作用-. 整形外科基礎科学, 11:印刷中, 1984.

• 17) Wiebkin, O. W., and Muir, H.:The inhibition of sulphate incorporation in isolated adult chondrocytes by hyaluronic acid. FEBS Letters, 37:42-46, 1973.
  pubmed

• 18) Solursh, H., Hardingham, T., Hascall, V., et al.:Separate effects of exogenous hyaluronic acid on proteoglycan synthesis and deposition in pericellular matrix by cultured chick embryo limb chondrocytes. Develop. Biol., 75:121-129, 1980.

• 19) Shinmei, M., Yokoi, A., Shimomura, Y., et al.:Influences of exogenous hyaluronic acid (HA) on proteoglycans (PG) metabolism of rabbit articular chondrocytes cultured in vitro. 15 th International Congress of Rheumatology (Paris), 1981.

• 20) Patterson, R. L, Peterson, D. A., Deinhardt, F., et al.:Rubella and rheumatoid arthritis, hyaluronic acid and susceptibility of cultured rheumatoid synovial cells to viruses. Pro. Soc. Exp. Biol. Med., 149:594-598, 1975.

• 21) Brandt, K. D.:The effect of synovial hyaluronate on the ingestion of monosodium urate crystals by leucocytes. Clin. Acta, 55:307-315, 1974.
  pubmed

• 22) Rosner, J. A., Boja, B. A., Malemud, C. J., et al.:Intra-articular hyaluronic acid injection and synovial prostaglandins in experimental immune synovitis. J. Rheumat., 10:71-78, 1983.

P.202 掲載の参考文献

• 1) Amor, B., Mery, C., and de Gery, A.:La tiopronine, nouvel antirhumatismal a action lente dans la polyarthrite rhumatoide. Rev. Rhum., 47:157-162, 1980.
  pubmed

• 2) Amor, B., Mery, C., and de Gery, A.:Tiopronin (N-〔2-mercaptopropionyl〕glycin) in rheumatoid arthritis. Arthritis Rheum., 25:698-703, 1982.
  pubmed

• 3) Camp, A. V.:Penicillamine in the treatment of rheumatoid arthritis. J. Rheum Suppl. No. 7:103-106, 1981.

• 4) Camus, J. P., Jaffe, I. A., Crouzet, J., Prier, A., Mercier, A., and Dubois, A.:La pyrithioxine, nouveau traitement de fond de la polyarthrite rhumatoide. Etude ouverte de soixante-douze cas avec un recul de six mois. Rev. Rhum., 45:95-100, 1978.

• 5) Camus, J. P., Crouzet, J., Prier, A., and Bergevin, H.:Pyrithioxine and thiopronine:new penicillamine-like drugs in rheumatoid arthritis. J. Rheum., Suppl. No. 7:175-177, 1981.

• 6) Dixon, A. St. J., Davies, J., Dormandy, T. L, Hamilton, E. B. D., Holt, P. J. L, Mason, R. M., Thompson, M., Weber J. C. P., and Zutshi, D. W.:Synthetic D(-)penicillamine in rheumatoid arthritis. Ann. Rheum. Dis., 34:416-421, 1975.

• 7) Huskisson, E. C., Jaffe, I. A., Scott, J., and Dieppe, P. A.:5-thiopyridoxine in rheumatoid arthritis:clinical and experimental studies. Arthritis Rheum., 23:106-110, 1980.
  pubmed

• 8) Passero, G., and Ciompi, M. L:Thiopronine therapy in rheumatoid arthritis. Arthritis Rheum., 22:803-804, 1979.

• 9) Passero, G., Pellegrini, P., Ciompi, M. L, Colamussi, V., Barbieri, P., and Massoni, M. R.:La tiopronine, nouveau traitement de fond de la polyarthrite rhumatoide. Rev. Rhum., 47:163-168, 1980.

• 10) Pasero, G., Pellegrini, P., Ambanelli, U., Ciompi, M.L, Colamussi, V., Ferraccioli, G., Barbieri, P., Mazzoni, M. R., Menegale, G., and Trippi, D.:Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis. Arthritis Rheum., 25:923-929, 1982.

• 11) Proceeding of International Symposium on Penicillamine:J. Rheum., Suppl. No. 7:1-181, 1981.

• 12) Nishibayashi Y., Shichikawa, K., Takenaka, Y., Kobayashi, I., and Doi, K.:Low and ultra-low dose penicillamine treatment in rheumatoid arthritis. Rev. Rhum., numero special, abstracts of XVth international congress of rheumatology, 0106, 1981.

• 13) 参天製薬株式会社研究部資料.

• 14) 七川歡次, 菅原幸子, 東 威, 有富 寛, 五十嵐三都男, 市川陽一, 斎藤 輝信, 高杉 潔, 鳥巣岳彦, 西岡久寿樹, 前田 晃, 蕨 治言:委員会が基準としている慢性関節リウマチに対する抗炎症・鎮痛剤の臨床試験実施基準方法. リウマチ, 23:254-267, 1983.

• 15) Shiokawa, Y., Horiuchi, Y., Honma, M., Kageyama, T., Okada, T., and Azuma, T.:Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum., 20:1464-1472, 1977.
  pubmed